TET2 and angioimmunoblastic T-cell lymphoma: From the initial identification of TET2 mutations in AITL and other nodal TFH lymphomas just over twenty years ago, significant strides have been made to advance the understanding of TET2’s role in the pathogenesis of these lymphomas.